Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
AC Immune $80 million at-the-market offering
We advised AC Immune on the offering
Banco Santander $1.5 billion Tier 1 capital securities offering
We advised Banco Santander on its SEC-registered offering of contingent convertible securities
Aptiv $3 billion accelerated share repurchase
We advised Aptiv on the ASR transactions
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Morgan Stanley Bank $2.5 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
Morgan Stanley $5.5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Banco Santander $3.75 billion notes offering
We advised Banco Santander on its offering of notes
SMFG $4.5 billion senior and subordinated notes offerings
We advised SMFG on its SEC-registered offerings of TLAC notes
XP $500 million senior notes offering and concurrent tender offer
We advised XP on its Rule 144A / Regulation S unsecured notes offering and concurrent tender offer
Hertz $1 billion financing
We advised Hertz on the transactions